Informação do paciente | Balao Allurion Elipse

Choose your country or region in order to display more relevant content.

Selecionar

Other country or region

País

Idioma

Continuar

Informação ao paciente

Quer você esteja prestes a fazer a sua colocação ou se encontre no meio do seu Programa de 16 semanas, estamos aqui para ajudá-lo durante a sua jornada.

O que esperar

Saiba o que pode esperar em cada passo da sua jornada de emagrecimento

Perguntas mais frequentes

Tenha respostas dos nossos especialistas em emagrecimento

Área do paciente

Acesse aos seus dados e estatísticas no portal online

Comece a trabalhar com os seus dispositivos

Como configurar a sua Balança Conectada Allurion e o Allurion Health Tracker

Junte-se à Comunidade

Faça hoje login na Área de Pacientes para acompanhar o seu progresso

La bilancia e l'orologio Allurion Health Tracker e l'applicazione mobile Allurion.

Suporte Técnico para Dispositivos Allurion

Faça download dos nossos recursos grátis para a sua Balança Conectada Allurion, Allurion Health Tracker e aplicativo

*As with any medical solution, results may vary from one patient to another, and some patients may not respond to treatment. Please consult a doctor to carefully evaluate the risks and benefits before making your decision.
**The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical intervention. In rare cases, instead of being expelled through the digestive tract, the empty balloon may be vomited out.
***Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a careful review of your medical history. In the case of an extended Allurion Program, your eligibility is reassessed before each placement to ensure you continue to meet the required conditions.

R. Ienca et al. The procedureless ellipse gastric balloon program: Multicenter experience in 1770 consecutive patients. Obes surg. 2020;30(9):3354-3362. Multicenter, prospective, non-randomized, open registry study conducted in patients with overweight or obesity from January 2016 to June 2019 in 19 international obesity centers participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m2 at baseline underwent treatment with the Elipse swallowable gastric balloon, with a monthly visit and a total follow-up of 4 months. 63 patients (3.6%) did not complete the program, and the balloon was removed before 4 months due to intolerance or other adverse effects.
World Health Organization – Key facts on Obesity and overweight (who.int).
European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful – EASO.
This information is extracted from the instructions for use of the Allurion Gastric Balloon System. Version number CS137-02-ENG. If you have any questions regarding this document, please consult your doctor.

Chat with Ally

Pacientes

Informação ao paciente

Referências